摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-[(1,2-oxazinan-2-yl)sulfonyl]hexan-1-amine | 1170231-83-0

中文名称
——
中文别名
——
英文名称
6-[(1,2-oxazinan-2-yl)sulfonyl]hexan-1-amine
英文别名
6-[(1,2-Oxazinan-2-yl)sulfonyl]hexan-1-amine;6-(oxazinan-2-ylsulfonyl)hexan-1-amine
6-[(1,2-oxazinan-2-yl)sulfonyl]hexan-1-amine化学式
CAS
1170231-83-0
化学式
C10H22N2O3S
mdl
——
分子量
250.362
InChiKey
ILVVUWDGRINYCJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    16
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    81
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

  • 作为反应物:
    描述:
    6-[(1,2-oxazinan-2-yl)sulfonyl]hexan-1-amine盐酸三乙基硅烷4-二甲氨基吡啶tin溶剂黄146三乙胺三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 反应 88.0h, 生成 2-{6-[(1,2-oxazinan-2-yl)sulfonyl]hexyl}-1,2-dihydro-3H-pyrrolo[3,4-c]pyridin-3-one
    参考文献:
    名称:
    The synthesis of some sulfonamides based on 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine
    摘要:
    Synthetic protocols for the preparation of 1-oxo-, 3-oxo-, and 1,3-dioxopyrrolo[3,4-c] pyridines which contain sulfonamide groups linked to the pyrrole nitrogen atom of the pyrrolo[3,4-c] pyridine cycle by a flexible (CH2) 6 aliphatic linker were developed. 1,3-Dioxopyrrolo-[3,4-c] pyridines were obtained from 3,4-pyridinedicarboxylic acid by condensation of intermediate methyl 3-(chlorocarbonyl)isonicotinate with amines. 3-Oxopyrrolo[3,4-c] pyridines were prepared by regioselective reduction of 1,3-dioxopyrrolo[3,4-c] pyridines with a tin dust followed by treatment with triethylsilane. 1-Oxopyrrolo[3,4-c] pyridines were prepared by a synthetic sequence consisting of the treatment of methyl isonicotinate with N-bromosuccinimide and the following condensation of the obtained ethyl 3-bromomethylisonicotinate with primary amines.
    DOI:
    10.1007/s10593-015-1753-y
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL CYANOGUANIDINES<br/>[FR] NOUVELLES CYANOGUANIDINES
    申请人:TOPOTARGET AS
    公开号:WO2009086835A1
    公开(公告)日:2009-07-16
    This application discloses novel cyanoguanidines of the formula (I) wherein A is selected from -C(=O)-, -S(=O)2-, -C(=S)-, and -P(=O)(R5)-, wherein R5 is selected from C1-6-alkyl, C1-6-alkoxy, and hydroxy; B is selected from a single bond, -O-, -NR6- and -C(=O)-NR6-, wherein R6 is selected from hydrogen, optionally substituted C1-12-alkyl, optionally substituted C1-12-alkenyl, optionally substituted aryl, optionally substituted heterocyclyl, and optionally substituted heteroaryl; and m is an integer of 0-12 and n is an integer of 0-12, wherein the sum m+n is 1-20; and R1 is selected from optionally substituted heteroaryl; and pharmaceutically acceptable salts thereof, and prodrugs thereof. The compounds are usefuld for use as a medicament for the treatment of a disease or a condition caused by an elevated level of nicotinamide phosphoribosyltransferase (NAMPRT).
    该申请公开了一种新型氰胍啶化合物,其化学式为(I),其中A从-C(=O)-,-S(=O)2-,-C(=S)-和-P(=O)(R5)-中选择,其中R5选择自C1-6-烷基,C1-6-烷氧基和羟基;B从单键,-O-,-NR6-和-C(=O)-NR6-中选择,其中R6选择自氢,可选择地取代的C1-12-烷基,可选择地取代的C1-12-烯基,可选择地取代的芳基,可选择地取代的杂环烷基和可选择地取代的杂环芳基;m为0-12的整数,n为0-12的整数,其中m+n之和为1-20;R1选择自可选择地取代的杂环芳基;以及其药学上可接受的盐和前药。这些化合物可用作治疗由烟酰胺磷酸核糖转移酶(NAMPRT)水平升高引起的疾病或病况的药物。
  • The synthesis of some sulfonamides based on 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine
    作者:Martins Ikaunieks、Fredrik Björkling、Einars Loza
    DOI:10.1007/s10593-015-1753-y
    日期:2015.7
    Synthetic protocols for the preparation of 1-oxo-, 3-oxo-, and 1,3-dioxopyrrolo[3,4-c] pyridines which contain sulfonamide groups linked to the pyrrole nitrogen atom of the pyrrolo[3,4-c] pyridine cycle by a flexible (CH2) 6 aliphatic linker were developed. 1,3-Dioxopyrrolo-[3,4-c] pyridines were obtained from 3,4-pyridinedicarboxylic acid by condensation of intermediate methyl 3-(chlorocarbonyl)isonicotinate with amines. 3-Oxopyrrolo[3,4-c] pyridines were prepared by regioselective reduction of 1,3-dioxopyrrolo[3,4-c] pyridines with a tin dust followed by treatment with triethylsilane. 1-Oxopyrrolo[3,4-c] pyridines were prepared by a synthetic sequence consisting of the treatment of methyl isonicotinate with N-bromosuccinimide and the following condensation of the obtained ethyl 3-bromomethylisonicotinate with primary amines.
查看更多

同类化合物

(4-甲基环戊-1-烯-1-基)(吗啉-4-基)甲酮 (2-肟基-氰基乙酸乙酯)-N,N-二甲基-吗啉基脲六氟磷酸酯 鲸蜡基乙基吗啉氮鎓乙基硫酸盐 马啉乙磺酸钾 预分散OTOS-80 顺式4-(氮杂环丁烷-3-基)-2,2-二甲基吗啉 顺式-N-亚硝基-2,6-二甲基吗啉 顺式-3,5-二甲基吗啉 顺-2,6-二甲基-4-(4-硝基苯基)吗啉 非屈酯 雷奈佐利二聚体 阿瑞杂质9 阿瑞吡坦磷的二卞酯 阿瑞吡坦杂质 阿瑞吡坦杂质 阿瑞吡坦 阿瑞吡坦 阿瑞匹坦非对映异构体2R3R1R 阿瑞匹坦杂质A异构体 阿瑞匹坦杂质54 阿瑞匹坦-M3代谢物 钾[2 - (吗啉- 4 -基)乙氧基]甲基三氟硼酸 邻苯二甲酸单吗啉 调节安 试剂2-(4-Morpholino)ethyl2-bromoisobutyrate 茂硫磷 苯甲腈,2-(4-吗啉基)-5-[1,4,5,6-四氢-4-(羟甲基)-6-羰基-3-哒嗪基]- 苯甲曲秦 苯甲吗啉酮 苯基2-(2-苯基吗啉-4-基)乙基碳酸酯盐酸盐 苯二甲吗啉一氢酒石酸盐 苯二甲吗啉 苯乙酮 O-(吗啉基羰基甲基)肟 芬美曲秦 芬布酯盐酸盐 芬布酯 脾脏酪氨酸激酶(SYK)抑制剂 脱氯利伐沙班 脱氟雷奈佐利 羟基1-(3-氯苯基)-2-[(1,1-二甲基乙基)氨基]-1-丙酮盐酸盐 福沙匹坦苄酯 福沙匹坦杂质26 福曲他明 碘化N-甲基丙基吗啉 碘化N-甲基,乙基吗啉 硝酸吗啉 盐酸吗啡啉-D8 甲基吗啉-2-羧酸甲酯2,2,2-三氟乙酸盐 甲基N-[3-(乙酰基氨基)-4-[(2-氰基-4,6-二硝基苯基)偶氮]苯基]-N-乙基-&#x3B2-丙氨酸酸酯 甲基4-吗啉二硫代甲酸酯